Agilitas Private Equity LLP is an authorised representative of Agilitas Partners LLP,
which is authorised and regulated by the UK Financial Conduct Authority  Disclaimer

July 2024

Agilitas-backed Prodieco expands global footprint with GEMEL acquisition

Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, has today announced that its portfolio company, Prodieco Limited (“Prodieco” or “the Company”), the largest independent non-OEM producer of blister tooling format change parts globally, has entered into an agreement to acquire the assets of GEMEL Precision Tooling (“GEMEL”), of Ivyland Pennsylvania, USA.

GEMEL is a leading provider of bespoke precision engineering solutions and parts to the life sciences sector in North America. Based in Pennsylvania, USA and with over 40 years of industry experience, GEMEL has established itself as a reliable and trusted partner to the pharmaceutical industry with a strong manufacturing infrastructure.

This strategic acquisition is an important step in Prodieco’s plan to establish top quality manufacturing and engineering capabilities in the USA, enabling market-leading customer service and delivery times to the North American market, whilst also providing a strategic location to further support the Central and South American markets.

Since Agilitas backed the buyout of Prodieco in December 2021, the company has focused on implementing multi-dimensional business transformations. Agilitas and management have been working to expand Prodieco’s scope to develop and deliver the highest quality blister tooling solutions and plans to bring its precision engineering skills to new markets to benefit more end patients.

For its achievements, Prodieco was awarded the “Life Sciences Exporter of the Year” in 2022 by the Irish Exporters Association. The Company also announced earlier this year a partnership with Rotzinger Pharma Packaging, a leading packaging machine producer, to set a new superior standard in the industry for blister packaging solutions.

Lisa Ainsworth, CEO of Prodieco, said:

“This transaction represents a significant value creation opportunity for Prodieco. The acquisition strengthens our presence in important markets across the Americas and will enhance our manufacturing and delivery capabilities in the region while providing an important platform for future development opportunities. We welcome the GEMEL team to Prodieco and look forward to working with them on the next phase of our growth journey.”  

Martin Calderbank, Managing Partner at Agilitas, commented:

“The agreement to acquire GEMEL marks the continued expansion of Prodieco’s global footprint and extension of its six-decades heritage of manufacturing high-quality and innovative solutions for blister packaging. The acquisition enables Prodieco to deliver its fundamental purpose of providing safer and more effective ways to take medication for more patients all over the world.”

Media enquiries to: Greenbrook Communications – James Madsen and Teresa Berezowski

+44 20 7952 2000 |